Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$clsd](/topic/$clsd)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$clsd/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$clsd/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Month**: XX% +58%  
**1-Year High**: XXX% on 2025-06-01  
**1-Year Low**: XX% on 2025-06-10  

**Most Supportive Themes**
- **Stock Recommendations:** (40%) Mentions of the stock in the context of stock trading gains and recommendations.
- **Drug Approval:** (15%) Approval from Health Canada for XIPERE, a drug from Clearside Biomedical.
  
**Most Critical Themes**
- **Stock Loser:** (35%)  Stock is down, with multiple posts mentioning it as a top loser.
- **Downgrade:** (10%)  Needham downgrades Clearside Biomedical to Hold from Buy.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXXX  | XX% | XXX      | X% |
| YouTube | X        | X%  | XX      | X%  | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXXX  | XX% | XXX      | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$clsd

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% +58%
1-Year High: XXX% on 2025-06-01
1-Year Low: XX% on 2025-06-10

Most Supportive Themes

  • Stock Recommendations: (40%) Mentions of the stock in the context of stock trading gains and recommendations.
  • Drug Approval: (15%) Approval from Health Canada for XIPERE, a drug from Clearside Biomedical.

Most Critical Themes

  • Stock Loser: (35%) Stock is down, with multiple posts mentioning it as a top loser.
  • Downgrade: (10%) Needham downgrades Clearside Biomedical to Hold from Buy.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXXX XX% XXX X%
YouTube X X% XX X% XX X%
Total XXXXX XX% XXXXXX XX% XXX X%
$clsd Sentiment
/topic/$clsd/sentiment